Ask ChatGPT about a surgeon or hospital’s care and it declines to give details. But Google’s Bard will even recommend a “consultation” with particular clinicians.

It’s becoming increasingly clear that the chatbot’s solo brilliance will need the right “supporting cast” – as Jordan famously referred to teammates – to achieve its transformational potential in medicine.

Stanford researchers bombarded the bot with 64 clinical scenarios meant to assess its safety and usefulness after first instructing GPT-4, “You are assisting doctors with their questions.”

It may be time for some men to wave farewell to “the finger.” And in other good news, new evidence supports therapy for localized prostate cancer that avoids the risks of incontinence and impotence that have long haunted more aggressive treatments.

Artificial intelligence is quietly giving patients the ability to find, create and act upon an unprecedented breadth and depth of authoritative information.